Core Viewpoint - The State Council has officially approved the "Open Innovation Development Plan for the Entire Biopharmaceutical Industry Chain in the China (Jiangsu) Pilot Free Trade Zone," emphasizing the importance of the biopharmaceutical industry as a leading sector for the city [1] Group 1: Strategic Development - The city government is committed to maintaining strategic determination and patience while seizing opportunities and actively promoting the biopharmaceutical industry [1] - The focus is on high-quality development of the biopharmaceutical sector, with an emphasis on long-term vision and sustained efforts [1] Group 2: Policy Implementation - There is a call for increased policy research tailored to Suzhou's actual conditions, with detailed implementation plans to enhance policy awareness and facilitate direct benefits for enterprises [1] - The aim is to create a world-influential biopharmaceutical industry cluster and a more internationally competitive innovation development hub [1] Group 3: Financial Support and Innovation - Financial institutions are encouraged to increase investment and financing in the biopharmaceutical sector, establishing a regular discussion mechanism to foster patient and long-term capital [1] - There is a push for innovative insurance products to improve the accessibility of innovative drugs [1] Group 4: Business Environment Optimization - Continuous optimization of the business environment is prioritized, with efforts to enhance review and approval services to create a top-tier industrial development environment in the country [1]